VIP treatment for arthritis
Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory responses.
May 1, 2001
Rheumatoid arthritis is an autoimmune disease characterized by chronic joint inflammation and subsequent destruction of the associated cartilage and bone. In May
Using a murine model of arthritis, Delgado
In an accompanying News & Views article Gary Firestein from UCSD School of Medicine La Jolla, California says...